GALE Stock Overview
Operates as a healthcare service provider in Switzerland and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 1/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
No risks detected for GALE from our risk checks.
My Notes
Capture your thoughts, links and company narrative
Galenica AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CHF 73.85 |
| 52 Week High | CHF 78.15 |
| 52 Week Low | CHF 69.30 |
| Beta | 0.19 |
| 1 Month Change | -1.53% |
| 3 Month Change | 1.30% |
| 1 Year Change | 2.21% |
| 3 Year Change | 11.05% |
| 5 Year Change | 21.97% |
| Change since IPO | 71.74% |
Recent News & Updates
Galenica AG's (VTX:GALE) Popularity With Investors Is Under Threat From Overpricing
Nov 12
Galenica (VTX:GALE) Seems To Use Debt Quite Sensibly
Oct 05Galenica (VTX:GALE) Might Have The Makings Of A Multi-Bagger
Sep 17Earnings Not Telling The Story For Galenica AG (VTX:GALE)
Jul 31Is Galenica (VTX:GALE) Using Too Much Debt?
Jun 16Recent updates
Galenica AG's (VTX:GALE) Popularity With Investors Is Under Threat From Overpricing
Nov 12Galenica (VTX:GALE) Seems To Use Debt Quite Sensibly
Oct 05Galenica (VTX:GALE) Might Have The Makings Of A Multi-Bagger
Sep 17Earnings Not Telling The Story For Galenica AG (VTX:GALE)
Jul 31Is Galenica (VTX:GALE) Using Too Much Debt?
Jun 16Galenica AG (VTX:GALE) Investors Are Less Pessimistic Than Expected
Apr 25We Think The Compensation For Galenica AG's (VTX:GALE) CEO Looks About Right
Apr 04Slowing Rates Of Return At Galenica (VTX:GALE) Leave Little Room For Excitement
Mar 29Pinning Down Galenica AG's (VTX:GALE) P/E Is Difficult Right Now
Jan 22Is There An Opportunity With Galenica AG's (VTX:GALE) 42% Undervaluation?
Jan 04Returns On Capital At Galenica (VTX:GALE) Have Hit The Brakes
Oct 26Is Galenica (VTX:GALE) Using Too Much Debt?
Oct 11Are Investors Undervaluing Galenica AG (VTX:GALE) By 42%?
Sep 26These 4 Measures Indicate That Galenica (VTX:GALE) Is Using Debt Reasonably Well
Jun 20Here's What To Make Of Galenica's (VTX:GALE) Decelerating Rates Of Return
Apr 17We Think Galenica (VTX:GALE) Can Stay On Top Of Its Debt
Mar 12Returns On Capital At Galenica (VTX:GALE) Have Hit The Brakes
Jan 08These 4 Measures Indicate That Galenica (VTX:GALE) Is Using Debt Reasonably Well
Nov 28The Returns At Galenica (VTX:GALE) Aren't Growing
Sep 20Is Galenica (VTX:GALE) A Risky Investment?
Aug 30Return Trends At Galenica (VTX:GALE) Aren't Appealing
Jun 15Galenica (VTX:GALE) Could Easily Take On More Debt
Apr 06Galenica (VTX:GALE) Has More To Do To Multiply In Value Going Forward
Feb 15Should You Be Adding Galenica (VTX:GALE) To Your Watchlist Today?
Jan 02Does Galenica (VTX:GALE) Have A Healthy Balance Sheet?
Nov 30Returns At Galenica (VTX:GALE) Appear To Be Weighed Down
Oct 24With EPS Growth And More, Galenica (VTX:GALE) Is Interesting
Sep 25Galenica (VTX:GALE) Seems To Use Debt Quite Sensibly
Aug 24Galenica (VTX:GALE) Has More To Do To Multiply In Value Going Forward
Jul 24If You Like EPS Growth Then Check Out Galenica (VTX:GALE) Before It's Too Late
Jun 12Investors Met With Slowing Returns on Capital At Galenica (VTX:GALE)
Apr 07Galenica (VTX:GALE) Seems To Use Debt Quite Sensibly
Mar 25Galenica AG Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Mar 11Is Galenica AG (VTX:GALE) The Right Choice For A Smart Dividend Investor?
Feb 27Are Institutions Heavily Invested In Galenica AG's (VTX:GALE) Shares?
Jan 31
Galenica (VTX:GALE) Shareholders Have Enjoyed A 25% Share Price Gain
Jan 13Is Galenica (VTX:GALE) Likely To Turn Things Around?
Dec 25Is Galenica (VTX:GALE) A Risky Investment?
Dec 09Is Galenica AG (VTX:GALE) An Attractive Dividend Stock?
Nov 24Shareholder Returns
| GALE | CH Healthcare | CH Market | |
|---|---|---|---|
| 7D | -1.8% | -0.5% | 0.5% |
| 1Y | 2.2% | 5.1% | 3.5% |
Return vs Industry: GALE underperformed the Swiss Healthcare industry which returned 6.8% over the past year.
Return vs Market: GALE matched the Swiss Market which returned 3.1% over the past year.
Price Volatility
| GALE volatility | |
|---|---|
| GALE Average Weekly Movement | 1.9% |
| Healthcare Industry Average Movement | 4.2% |
| Market Average Movement | 3.4% |
| 10% most volatile stocks in CH Market | 6.8% |
| 10% least volatile stocks in CH Market | 1.6% |
Stable Share Price: GALE has not had significant price volatility in the past 3 months compared to the Swiss market.
Volatility Over Time: GALE's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1927 | 7,955 | Marc Werner | www.galenica.com |
Galenica AG operates as a healthcare service provider in Switzerland and internationally. It operates through two segments, Products & Care, and Logistics & IT. The Products & Care segment operates pharmacies and partner pharmacies under the Amavita, Sun Store, and Coop Vitality brands.
Galenica AG Fundamentals Summary
| GALE fundamental statistics | |
|---|---|
| Market cap | CHF 3.68b |
| Earnings (TTM) | CHF 169.68m |
| Revenue (TTM) | CHF 3.80b |
21.7x
P/E Ratio1.0x
P/S RatioIs GALE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| GALE income statement (TTM) | |
|---|---|
| Revenue | CHF 3.80b |
| Cost of Revenue | CHF 3.34b |
| Gross Profit | CHF 464.58m |
| Other Expenses | CHF 294.90m |
| Earnings | CHF 169.68m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Mar 11, 2025
| Earnings per share (EPS) | 3.41 |
| Gross Margin | 12.22% |
| Net Profit Margin | 4.46% |
| Debt/Equity Ratio | 42.9% |
How did GALE perform over the long term?
See historical performance and comparisonDividends
3.0%
Current Dividend Yield65%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/17 04:22 |
| End of Day Share Price | 2024/12/17 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Galenica AG is covered by 12 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Bruno Bulic | Baader Helvea Equity Research |
| Volker Bosse | Baader Helvea Equity Research |
| Alexander Berglund | BofA Global Research |